PAS
ABBV icon

Parsonex Advisory Services’s AbbVie ABBV Stock Holding History

Parsonex Advisory Services’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,659
Closed -$379K – 57
2025
Q4 		$379K Buy
1,659
+117
+8% +$26.7K 0.24% 64
2025
Q3 		$357K Sell
1,542
-183
-11% -$37.3K 0.24% 68
2025
Q2 		$320K Buy
+1,725
New +$321K 0.27% 75

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Parsonex Advisory Services's ABBV Position: Q1 2026 in Review

Parsonex Advisory Services sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 1,659 shares — an estimated $379K sold.

Parsonex Advisory Services first reported a position in ABBV in Q2 2025 and held it in 3 quarters. The position peaked at $379K in Q4 2025. 4,097 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Parsonex Advisory Services reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
  • Parsonex Advisory Services sold 1,659 AbbVie shares in Q1 2026, an estimated $379K.
  • Parsonex Advisory Services first reported a position in AbbVie in Q2 2025 and held it in 3 quarters.
  • Parsonex Advisory Services's AbbVie position peaked at $379K in Q4 2025.
  • 4,097 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Parsonex Advisory Services's 13F filing for Q1 2026, filed 12 May 2026.